Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Immunology|April 1, 2014
Timing and intensity of exposure to interferon-γ critically determines the function of monocyte-derived dendritic cellsSid P Kerkar, Dhanalakshmi Chinnasamy, Neima Hadi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2013
Collapse of the tumor stroma is triggered by IL-12 induction of FasSid P Kerkar, Anthony J Leonardi, Nicolas van Panhuys, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in miceChristopher A Klebanoff, Luca Gattinoni, Douglas C Palmer, et al.
The Journal of Clinical Investigation|November 8, 2011
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumorsSid P Kerkar, Romina S Goldszmid, Pawel Muranski, et al.
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studiesSid P Kerkar, Luis Sanchez-Perez, Shicheng Yang, et al.
Trials|December 25, 2009
The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy aloneSid P Kerkar, Clinton D Kemp, Austin Duffy, et al.
Ophthalmology|May 5, 2009
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanomaSteven Yeh, Neel K Karne, Sid P Kerkar, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanomaLing Zhang, Richard A Morgan, Joal D Beane, et al.
Pageof 3